Memorial Sloan Kettering Cancer Center 6th Annual MSK Symposium on Lymphoma 2022

20 $

+ Include: 32 videos + 33 pdfs, size: 9.6 GB

+ Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma

Description

+ Include: 32 videos + 33 pdfs, size: 9.6 GB

+ Target Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma

+ Sample video: contact me for sample video

+ Information:

Date & Location

Friday, May 13, 2022, 7:45 AM – Saturday, May 14, 2022, 1:20 PM, Online, New York, NY

Specialties
Specialties – Bone Marrow Transplant, Cellular Therapeutics, Hematology, Immunotherapy, Internal Medicine, Leukemia, Lymphoma, Medical Oncology, Nuclear Medicine, Oncology and Hematology
Overview

This symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes. This year, we will address the clinical management of the most frequent lymphoma entities, we will feature focused sessions related to new families of drugs being developed in these areas as well as in less common presentations. Faculty will present those and then discuss during a panel how to best approach patients’ situations. We will also cover in a special session recent advances in the biology of lymphoma and how this will translate to innovative therapeutic interventions. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biomarkers and imaging into clinical practice and clinical trials.

Who Should Attend

The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

Objectives
  1. Describe recent refinements in lymphoma classification
  2. Discuss first line treatment options in most frequent lymphoma entities
  3. Identify risks/benefits of new approved agents
  4. Implement standard of care changes for patients with lymphoma
  5. Educate patients on the disease and treatment options

 

+ Topics:

Advanced Stage Hodgkin Lymphoma- What Now..mp4
Advanced Stage Hodgkin Lymphoma- What Now..pdf
Bispecific Antibodies in B-cell Lymphoma- A New Breakthrough.mp4
Bispecific Antibodies in B-cell Lymphoma- A New Breakthrough.pdf
Building on R-CHOP to Improve DLBCL Outcomes.mp4
Building on R-CHOP to Improve DLBCL Outcomes.pdf
CAR T Cell Therapy for Transplant Eligible and Ineligible.mp4
CAR T Cell Therapy for Transplant Eligible and Ineligible.pdf
Chipping Away at CHOP- Can First Line Therapy Really be Chemotherapy Free..mp4
Chipping Away at CHOP- Can First Line Therapy Really be Chemotherapy Free..pdf
CLL- State-of-the-Art Management and Recent Innovations.mp4
CLL- State-of-the-Art Management and Recent Innovations.pdf
CNS Prophylaxis in DLBCL- Navigating New Data.mp4
CNS Prophylaxis in DLBCL- Navigating New Data.pdf
Considerations for Relapsed and Refractory Marginal Zone Lymphoma.mp4
Considerations for Relapsed and Refractory Marginal Zone Lymphoma.pdf
CTCL- Current Management and Future Directions.mp4
CTCL- Current Management and Future Directions.pdf
Driving CAR T cells Forward.mp4
Driving CAR T cells Forward.pdf
Early Relapse DLBCL- CAR T Cell for Selected Patients.mp4
Early Relapse DLBCL- CAR T Cell for Selected Patients.pdf
Follicular Lymphoma Microenvironment- What About Stromal Cell Origin and Function..mp4
Follicular Lymphoma Microenvironment- What About Stromal Cell Origin and Function..pdf
Improving BTK and PI3K Inhibitors.mp4
Improving BTK and PI3K Inhibitors.pdf
Lymphoma2022_Brochure.pdf
Managing Waldenstr”m Macroglobulinemia in 2022.pdf
New Directions for the Frontline treatment of MCL.mp4
New Directions for the Frontline treatment of MCL.pdf
New Frontiers for Radiotherapy in Lymphoma- Doing More with Less and Doing More with More.mp4
New Frontiers for Radiotherapy in Lymphoma- Doing More with Less and Doing More with More.pdf
New Therapeutic Approaches in T-cell Lymphoma.mp4
New Therapeutic Approaches in T-cell Lymphoma.pdf
Novel Targets for Imaging of Lymphoma and Microenvironment.mp4
Novel Targets for Imaging of Lymphoma and Microenvironment.pdf
Optimizing Therapy in Early Stage Classic Hodgkin Lymphoma.mp4
Optimizing Therapy in Early Stage Classic Hodgkin Lymphoma.pdf
Options for First Line Management of Marginal Zone Lymphoma.mp4
Options for First Line Management of Marginal Zone Lymphoma.pdf
Options for Managing RR Follicular Lymphoma.mp4
Options for Managing RR Follicular Lymphoma.pdf
Personalizing First Line Therapy in Patients with Follicular Lymphoma.mp4
Personalizing First Line Therapy in Patients with Follicular Lymphoma.pdf
Plenary Lecture- Adaptive Immune Dysregulation in Cancer Patients During SARS-CoV-2 Infection and Vaccination.mp4
Plenary Lecture- Adaptive Immune Dysregulation in Cancer Patients During SARS-CoV-2 Infection and Vaccination.pdf
Plenary Lecture- Circulating Tumor DNA in Lymphoma- Principles Learned and Future Directions.mp4
Plenary Lecture- Circulating Tumor DNA in Lymphoma- Principles Learned and Future Directions.pdf
Recent Advances in the Biology of MALT Lymphoma.mp4
Recent Advances in the Biology of MALT Lymphoma.pdf
Recent Concepts in DLBCL High Grade B-cell Lymphomas.mp4
Recent Concepts in DLBCL High Grade B-cell Lymphomas.pdf
Roundtable Discussion.mp4
Strategies to Overcome Immunological Barriers in the Microenvironment in Lymphoma.mp4
Strategies to Overcome Immunological Barriers in the Microenvironment in Lymphoma.pdf
The High Cost of Cancer Drugs and What We Need to Do About It.mp4
The High Cost of Cancer Drugs and What We Need to Do About It.pdf
The Role of PD1 in Cutaneous T Cell Lymphomas.mp4
The Role of PD1 in Cutaneous T Cell Lymphomas.pdf
Understanding Immunotherapy Resistance of B-cell Non-Hodgkin Lymphomas.mp4
Understanding Immunotherapy Resistance of B-cell Non-Hodgkin Lymphomas.pdf
Unmasking the Boogie Man- Novel Treatment Outpatients in RR Mantle Cell Lymphoma.mp4
Unmasking the Boogie Man- Novel Treatment Outpatients in RR Mantle Cell Lymphoma.pdf
Updates in Management of Relapsed and Refractory Hodgkin Lymphoma.mp4
Updates in Management of Relapsed and Refractory Hodgkin Lymphoma.pdf

Reviews

There are no reviews yet.

Be the first to review “Memorial Sloan Kettering Cancer Center 6th Annual MSK Symposium on Lymphoma 2022”

Your email address will not be published. Required fields are marked *